Features
Decision Intelligence in Glaucoma Care
Integrating advanced analytics with clinical data can improve management decisions and patient outcomes.
By Lama A. Al-Aswad, MD, MPH, Almiqdad Saeed, MD
Things You Didn’t Know About SLT
Experienced surgeons dispel myths about selective laser trabeculoplasty and provide pearls and practice insights.
By Syril K. Dorairaj, MD, and, Ariana Levin, MD, Tony Realini, MD, MPH, et al.
Home Tonometry Benefits and Limitations
Clinical considerations for incorporating home IOP monitoring into glaucoma care.
By Lama Assi, MD, Cara E. Capitena Young, MD
Are We Ready for Concierge Glaucoma Care?
Optimized workflow and thoughtful access planning are the foundation of a successful concierge ophthalmology practice.
By Joseph F. Panarelli, MD
Nutritional Supplementation in Glaucoma
Evidence points to neuroprotective and vasoregulatory effects of dietary supplements and nutrients in glaucoma management.
By Cecily L. Kaufmann, BSN, Samantha Goldburg, MD, Rachel Chapman, et al.
Departments
Why Do Half of Cataract Surgeons Avoid MIGS?
From the Editor: Despite patient acceptance and expanding options, surgeon hesitation remains a major barrier to broader MIGS adoption.
By Nathan M. Radcliffe, MD
Digital Duet 2.0 Expands SLT+YAG Capabilities
Spotlight: Lumenis updates its combined laser platform with enhanced imaging, workflow integration, and documentation tools for glaucoma and posterior capsulotomy.
By Jim Gallagher, senior managing editor
Understanding and Using Modifier -24
Coding: Proper use of modifier -24 is essential to accurately bill postoperative E/M services that are unrelated to a prior procedure.
By Kevin J. Corcoran, COE, FNAO
Glaucoma Trials Tracker
Access Glaucoma Physician's listing of all active interventional clinical trials related to glaucoma.
News
Diurnal IOP Fluctuation Drops After SLT, Study Finds
A small prospective study using home tonometry showed sustained reductions in intraocular pressure variability through 18 months.
By Jim Gallagher, senior managing editor
Video: Predicting Glaucoma Progression with AI
Cecilia S. Lee, MD, MS, explores how deep learning models could enable earlier intervention and better outcomes.
By Cecilia S. Lee, MD, MS
New Possibilities for Minimally Invasive Bleb Surgery
At AGS 2026, Ian F. Pitha, MD, PhD, discussed the current role of MIBS and reviewed investigational devices under development.
By Jim Gallagher, senior managing editor
The Evolving MIGS Pipeline
At AGS 2026, Rachel Simpson, MD, highlighted the latest investigational technologies in minimally invasive glaucoma surgery.
By Jim Gallagher, senior managing editor
Understanding FDA Pathways for MIGS
At AGS 2026, Douglas J. Rhee, MD, provided a practical overview of device regulation and its implications for MIGS adoption and reimbursement.
By Jim Gallagher, senior managing editor
A Surgical Safety Net for Glaucoma Patients
The AGS Cares program matches patients in need with volunteer surgeons across the United States.
By Jim Gallagher, senior managing editor
Video: Study Reports Lower IOP, Fewer Medications With Omni
Researchers from Emory University reported meaningful IOP control and reduced glaucoma medications when combined with cataract surgery.
By Rebecca F. Neustein, MD, Chelsea-Jane Arcalas, MD
Xen Study Finds Ab Interno and Externo Approaches Equally Effective
Researchers from the University of Illinois College of Medicine found that both approaches reduce IOP, lower medications, and improve visual acuity.
By Evan Lagouros, MD, Cecilia Canizela, BS
The Future of Glaucoma Care: Protecting the Optic Nerve
In the 2026 AGS Lecture, Louis R. Pasquale, MD, FARVO, discussed how genetics, metabolism, and understanding the impact of myopia on the lamina support system may redefine optic nerve protection.
By Jim Gallagher, senior managing editor
Integrating AI into the Glaucoma Clinic
Newer artificial intelligence tools are designed to automate routine administrative tasks and improve practice efficiency.
By Jim Gallagher, senior managing editor
Laser-Titratable Shunt Achieves IOP Reduction at 12 Months
Data presented at AGS 2026 suggest the Calibreye system may offer pressure and medication reduction comparable to existing drainage implants.
By Jim Gallagher, senior managing editor
Video: Early iDose TREX Data Show Double-Digit IOP Reduction
Steven R. Sarkisian Jr., MD, reviews early results with the extended-release travoprost implant.
By Steven R. Sarkisian, Jr., MD
Which Patients Benefit Most From Repeat SLT?
A retrospective observational study of more than 279,000 eyes may help guide patient selection for repeat SLT.
By Wendy Liu, MD, PHD,
Video: Nanotechnology Meets Glaucoma Care
Avisi Technologies founder and CEO Rui Jing Jiang shares insights on the company’s VisiPlate shunt and other nanotechnologies, the VITA and SAPPHIRE trials, and the company’s vision for comprehensive glaucoma care.
By Rui Jing Jiang
Video: Novel Vasodilator Targets Distal Outflow
At AGS 2026, Barbara Wirostko, MD, FARVO, reviewed top-line data on QLS-111, including additive IOP lowering on latanoprost.
By Barbara M. Wirostko, MD, FARVO
Video: Medicare RVU Cuts Reduce Glaucoma Reimbursement
At AGS 2026, Andrew Pouw, MD, explained how changes to practice expense and work RVUs significantly lower Medicare reimbursement for surgeons.
By Andrew Pouw, MD
Implementing Sustainability: Why Small Changes Matter
At the American Glaucoma Society meeting, Aakriti Garg Shukla, MD, highlighted how small changes in surgical and clinic workflows can meaningfully improve sustainability across ophthalmic care.
By Aakriti Garg, MD
Navigating Drug Costs in Glaucoma Care
At AGS 2026, Lorraine M. Provencher, MD, outlined practical strategies for using patient assistance programs to reduce medication costs.
By Jim Gallagher, senior managing editor
Could Blood Flow Reveal Glaucoma Earlier?
A University of Maryland study finds that retinal blood-flow autoregulation may signal early glaucoma before structural damage or vision loss is detectable.
By Jim Gallagher, senior managing editor
Video: Low-Power Ultrasound Could Offer New Glaucoma Therapy
Preliminary trials in India suggest Tulip may help lower eye pressure, says Donald Schwartz, MD.
By Donald Schwartz, MD